These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9378048)

  • 21. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.
    Dequeker J; Westhovens R
    J Rheumatol; 1995 Jun; 22(6):1013-9. PubMed ID: 7674223
    [No Abstract]   [Full Text] [Related]  

  • 22. Risedronate: a new oral bisphosphonate.
    Roll KT
    Clin Ther; 2002 May; 24(5):835-6. PubMed ID: 12075950
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastroenterologists and choosing the right bisphosphonate.
    Leder BZ; Kronenberg HM
    Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
    [No Abstract]   [Full Text] [Related]  

  • 24. [Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches].
    Ringe JD
    Z Rheumatol; 1996; 55(3):149-57. PubMed ID: 8768144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etidronic acid and steroid therapy: new indication. No proven impact on fractures.
    Prescrire Int; 1999 Aug; 8(42):111-2. PubMed ID: 11503828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P; Laursen LC; Schwarz P; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):898-900. PubMed ID: 15789844
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of steroid-induced osteoporosis is not unique to ophthalmology.
    Pope J; McKeown E
    Can J Ophthalmol; 2010 Feb; 45(1):10-2. PubMed ID: 20130702
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risedronic acid and calcium + colecalciferol: new combination. A simple combination of two other products. A simple commercial ploy with no benefit for patients.
    Prescrire Int; 2008 Jun; 17(95):105. PubMed ID: 18623913
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y; Nagasaka Y
    Clin Calcium; 2007 Jun; 17(6):955-62. PubMed ID: 17548937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trend of an osteoporosis curative medicine--Who uses what from when to when how?].
    Yamazaki K
    Clin Calcium; 2004 Mar; 14(3):364-9. PubMed ID: 15576993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment].
    Negri AL; Spivacow FR; Zanchetta JR
    Medicina (B Aires); 1992; 52(3):257-64. PubMed ID: 1342693
    [No Abstract]   [Full Text] [Related]  

  • 35. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is therapy with calcium and vitamin D adequate in glucocorticoid induced and inflammation related osteoporosis?].
    Ringe D
    Z Rheumatol; 2005 Mar; 64(2):137. PubMed ID: 15793679
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
    Laroche C; Detilleux M; Sereni D
    Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of osteoporosis.
    Melick RA
    Med J Aust; 1986 Jun; 144(12):645-7. PubMed ID: 3520261
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of bisphosphates in treatment of primary and secondary osteoporosis].
    Olszyński WP
    Pol Tyg Lek; 1995 Nov; 50(44-47):56-8. PubMed ID: 8643431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diphosphonates in the treatment of osteoporosis].
    Papapoulos SE; Lockefeer JH
    Ned Tijdschr Geneeskd; 1991 Mar; 135(13):553-6. PubMed ID: 1902912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.